Company: JUNS
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001261
Chunk: 339

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 10
Chunk 339
---
. Hemmerly will be paid $4,000 annually to be paid $1,000
    each calendar quarter, with the amount for any partial calendar quarter being appropriately prorated.

Each
of the agreements contains customary confidentiality provisions, and customary provisions relating to intellectual property created by
the executive (i.e., a “work-made-for-hire” provision. Each of the agreements is governed by Delaware law and contains customary
representations and warranties and other miscellaneous provisions.

ITEM
12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The
following table sets forth information regarding the beneficial ownership of our common stock as of March 12, 2025 by:

    ●
    each
    person known by us to be the beneficial owner of more than 5% of our outstanding shares of common stock;

    ●
    each
    of our executive officers and directors that beneficially owns shares of our common stock; and

    ●
    all
    our executive officers and directors as a group.

In
the table below, percentage ownership is based on 33,103,860 shares of our common stock issued and outstanding as of March 12, 2025.
Unless otherwise noted below, the address for each beneficial owner listed on the table is c/o Jupiter Neurosciences, Inc., 1001 North
US Hwy 1, Suite 504, Jupiter, FL 33477. We have determined beneficial ownership in accordance with the rules of the SEC. We believe,
based on the information furnished to us, that the persons and entities named in the tables below have sole voting and investment power
with respect to all shares of common stock that they beneficially own, subject to applicable community property laws.

    Name and Address of Beneficial Owner 
    Amount and Nature of Shares Beneficial Ownership (1)
      
    Percentage of Class 
  
    Executive Officers and Directors: 

    Christer Rosén 
     12,571,758
    (2) 
     38.0%
  
    Marshall Hayward, Ph.D 
     3,625,382
    (3) 
     11.0 
  
    Saleem Elmasri 
     666,420
    (4) 
     2.0 
  
    Alison D. Silva 
     870,871
    (5) 
     2.6 
  
    Alexander Rosén 
     1,